A pilot study of peroral Vorinostat (Zolinza) in patients with refractory histone deacetylase-positive uterine sarcoma.
Phase of Trial: Phase II
Latest Information Update: 03 May 2018
At a glance
- Drugs Vorinostat (Primary)
- Indications Sarcoma; Uterine cancer
- Focus Proof of concept; Therapeutic Use
- 17 Jan 2017 New trial record